Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 May;60(5):1337-1339.
doi: 10.1080/10428194.2018.1522443. Epub 2018 Nov 8.

Novel germline missense DDX41 variant in a patient with an adult-onset myeloid neoplasm with excess blasts without dysplasia

Filippo Pinto E Vairo  1   2 , Alejandro Ferrer  1   2 , Elizabeth Cathcart-Rake  3 , Rebecca L King  3 , Matthew T Howard  3 , David S Viswanatha  4 , Eric W Klee  1   2   4   5 , Abhishek A Mangaonkar  3 , Mrinal M Patnaik  3
Affiliations
Case Reports

Novel germline missense DDX41 variant in a patient with an adult-onset myeloid neoplasm with excess blasts without dysplasia

Filippo Pinto E Vairo et al. Leuk Lymphoma. 2019 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interests

No conflict of interest.

Figures

Figure 1:
Figure 1:
Initial bone marrow aspirate smear and core biopsy. Panels A and B show bone marrow aspirate with increased numbers of small blasts with fine chromatin and basophilic cytoplasm. Erythroid precursors and granulocytic precursors show no significant dysplasia. Panel C shows the core biopsy with normocellular marrow for age and cytologically normal megakaryocytes and immature myeloid cells. CD34 stain (Panel D) shows 10-20% blasts (400×). Wright Giemsa, 1000× (A,B), Hematoxylin and Eosin, 400× (C).
See this image and copyright information in PMC

References

    1. Polprasert C, Schulze I, Sekeres MA, et al. Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms. Cancer Cell. 2015. May 11;27(5):658–70. doi: 10.1016/j.ccell.2015.03.017. PubMed PMID: . - DOI - PMC - PubMed
    1. Jerez A, Gondek LP, Jankowska AM, et al. Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited. J Clin Oncol. 2012. April 20;30(12):1343–9. doi: 10.1200/JCO.2011.36.1824. PubMed PMID: ; PubMed Central PMCID: PMCPMC3341146. - DOI - PMC - PubMed
    1. Berger G, van den Berg E, Sikkema-Raddatz B, et al. Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation. Leukemia. 2017. February;31(2):520–522. doi: 10.1038/leu.2016.310. PubMed PMID: . - DOI - PubMed
    1. Jagadeesh KA, Wenger AM, Berger MJ, et al. M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity. Nat Genet. 2016. December;48(12):1581–1586. doi: 10.1038/ng.3703. PubMed PMID: . - DOI - PubMed
    1. Bendl J, Musil M, Stourac J, et al. PredictSNP2: A Unified Platform for Accurately Evaluating SNP Effects by Exploiting the Different Characteristics of Variants in Distinct Genomic Regions. PLoS Comput Biol. 2016. May;12(5):e1004962. doi: 10.1371/journal.pcbi.1004962. PubMed PMID: ; PubMed Central PMCID: PMCPMC4880439. - DOI - PMC - PubMed